SynthesisActa diabetologica2026

Safety of SGLT-2 inhibitors in patients with glycogen storage disease type Ib and their efficacy in treating disease-associated digestive symptoms and disorders.

Ziqiu Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.